<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Oncohematology</journal-id><journal-title-group><journal-title xml:lang="en">Oncohematology</journal-title><trans-title-group xml:lang="ru"><trans-title>Онкогематология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1818-8346</issn><issn publication-format="electronic">2413-4023</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">70</article-id><article-id pub-id-type="doi">10.17650/1818-8346-2012-7-4-7-10</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>NEW TRENDS IN MEDICAL SCIENCE</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>НОВЫЕ НАПРАВЛЕНИЯ МЕДИЦИНСКОЙ НАУКИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Fullerene derivatives as modulators for the cell proliferation and apoptosis processes</article-title><trans-title-group xml:lang="ru"><trans-title>Производные фуллерена как модуляторы процессов клеточной пролиферации и апоптоза</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Orlova</surname><given-names>M. A.</given-names></name><name xml:lang="ru"><surname>Орлова</surname><given-names>М. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>Химический факультет, кафедра радиохимии</p></bio><email>orlova.radiochem@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Trofimova</surname><given-names>T. P.</given-names></name><name xml:lang="ru"><surname>Трофимова</surname><given-names>Т. П.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>Химический факультет, кафедра радиохимии</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Orlov</surname><given-names>A. P.</given-names></name><name xml:lang="ru"><surname>Орлов</surname><given-names>А. П.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>медико-биологический факультет, кафедра медицинских нанобиотехнологий</p></bio><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shatalov</surname><given-names>O. A.</given-names></name><name xml:lang="ru"><surname>Шаталов</surname><given-names>О. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>фармацевтический факультет, кафедра фармакологии</p></bio><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Svistunov</surname><given-names>A. A.</given-names></name><name xml:lang="ru"><surname>Свистунов</surname><given-names>А. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>фармацевтический факультет, кафедра фармакологии</p></bio><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Napolov</surname><given-names>Yu. K.</given-names></name><name xml:lang="ru"><surname>Наполов</surname><given-names>Ю. К.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>фармацевтический факультет, кафедра фармакологии</p></bio><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Chekhonin</surname><given-names>V. P.</given-names></name><name xml:lang="ru"><surname>Чехонин</surname><given-names>В. П.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>медико-биологический факультет, кафедра медицинских нанобиотехнологий</p></bio><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">M.V. Lomonosov Moscow State University</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВПО «Московский государственный университет им. М.В. Ломоносова»</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">N.I. Pirogov Russian National Research Medical University</institution></aff><aff><institution xml:lang="ru">ГБОУ ВПО «Российский научно-исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">I.M. Sechenov Moscow State Medical University</institution></aff><aff><institution xml:lang="ru">ГБОУ ВПО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2012-11-23" publication-format="electronic"><day>23</day><month>11</month><year>2012</year></pub-date><volume>7</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>7</fpage><lpage>10</lpage><history><date date-type="received" iso-8601-date="2014-07-22"><day>22</day><month>07</month><year>2014</year></date><date date-type="accepted" iso-8601-date="2014-07-22"><day>22</day><month>07</month><year>2014</year></date></history><permissions><copyright-year>2012</copyright-year><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://oncohematology.abvpress.ru/ongm/article/view/70">https://oncohematology.abvpress.ru/ongm/article/view/70</self-uri><abstract xml:lang="en"><p>.</p></abstract><trans-abstract xml:lang="ru"><p>.</p></trans-abstract><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Duncan R., Gaspar R. Nanomedicine(s) under the microscope. Mol Pharmaceutics 2011;8:2101–41.</mixed-citation><mixed-citation xml:lang="ru">Duncan R., Gaspar R. Nanomedicine(s) under the microscope. Mol Pharmaceutics 2011;8:2101–41.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Harhaji L., Isakovic A., Raicevic N. et al. Multiple mechanisms underlying the anticancer action of nanocrystalline fullerene. Eur J Pharmacol 2007;568:89–98.</mixed-citation><mixed-citation xml:lang="ru">Harhaji L., Isakovic A., Raicevic N. et al. Multiple mechanisms underlying the anticancer action of nanocrystalline fullerene. Eur J Pharmacol 2007;568:89–98.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Dugan L.L., Turetsky D.M., Du C. et al. Carboxyfullerenes as neuroprotective agents. Proc Natl Acad Sci (USA) 1997;94:9434–9.</mixed-citation><mixed-citation xml:lang="ru">Dugan L.L., Turetsky D.M., Du C. et al. Carboxyfullerenes as neuroprotective agents. Proc Natl Acad Sci (USA) 1997;94:9434–9.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Monti D., Moretti L., Salvioli S. et al. C60 carboxyfullerene exerts a protective activity against oxidative stress-induced apoptosis in human peripheral blood mononuclear cells. Biochem Biophys Res Commun 2000;277:711–7.</mixed-citation><mixed-citation xml:lang="ru">Monti D., Moretti L., Salvioli S. et al. C60 carboxyfullerene exerts a protective activity against oxidative stress-induced apoptosis in human peripheral blood mononuclear cells. Biochem Biophys Res Commun 2000;277:711–7.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Dugan L.L., Gabrielsen J.K., Yu S.P. et al. Buckminsterfullerenol free radical scavengers reduce excitotoxic and apoptotic death of cultured cortical neurons. Neurobiol Dis 1996;3:129–35.</mixed-citation><mixed-citation xml:lang="ru">Dugan L.L., Gabrielsen J.K., Yu S.P. et al. Buckminsterfullerenol free radical scavengers reduce excitotoxic and apoptotic death of cultured cortical neurons. Neurobiol Dis 1996;3:129–35.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Isakovic A., Markovic Z., Nikolic N. et al. Inactivation of nanocrystalline C60 cytotoxicity by γ-irradiation. Biomaterials 2006;27:5049–58.</mixed-citation><mixed-citation xml:lang="ru">Isakovic A., Markovic Z., Nikolic N. et al. Inactivation of nanocrystalline C60 cytotoxicity by γ-irradiation. Biomaterials 2006;27:5049–58.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Isakovic A., Markovic Z., Todorovic-Markovic B. et al. Distinct cytotoxic mechanisms of pristine versus hydroxylated fullerene. Toxicol Sci 2006;91:173–83.</mixed-citation><mixed-citation xml:lang="ru">Isakovic A., Markovic Z., Todorovic-Markovic B. et al. Distinct cytotoxic mechanisms of pristine versus hydroxylated fullerene. Toxicol Sci 2006;91:173–83.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Yamawaki H., Iwai N. Cytotoxicity of water-soluble fullerene in vascular endothelial cells. Am J Physiol Cell Physiol 2006;290:C1495–C1502.</mixed-citation><mixed-citation xml:lang="ru">Yamawaki H., Iwai N. Cytotoxicity of water-soluble fullerene in vascular endothelial cells. Am J Physiol Cell Physiol 2006;290:C1495–C1502.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9. Yang X.L., Fan C.H., Zhu H.S. Photoinduced cytotoxicity of malonic acid [C60] fullerene derivatives and its mechanism. Toxicol in Vitro 2002;16:41–6.</mixed-citation><mixed-citation xml:lang="ru">Yang X.L., Fan C.H., Zhu H.S. Photoinduced cytotoxicity of malonic acid [C60] fullerene derivatives and its mechanism. Toxicol in Vitro 2002;16:41–6.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">10. Rancan F., Rosan S., Boehm F. et al. Cytotoxicity and photocytotoxicity of a dendritic C60 mono-adduct and a malonic acid C60 tris-adduct on Jurkat cells. J Photochem Photobiol B 2002;67:157–62.</mixed-citation><mixed-citation xml:lang="ru">Rancan F., Rosan S., Boehm F. et al. Cytotoxicity and photocytotoxicity of a dendritic C60 mono-adduct and a malonic acid C60 tris-adduct on Jurkat cells. J Photochem Photobiol B 2002;67:157–62.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">11. Bosi S., Feruglio L., Da Ros T. et al. Hemolytic effects of water-soluble fullerene derivatives. J Med Chem 2004;47:6711–5.</mixed-citation><mixed-citation xml:lang="ru">Bosi S., Feruglio L., Da Ros T. et al. Hemolytic effects of water-soluble fullerene derivatives. J Med Chem 2004;47:6711–5.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">12. Chen C., Xing G., Wang J. et al. Multihydroxylated [Gd@C82(OH)22]n nanoparticles: antineoplastic activity of high efficiency and low toxicity. Nano Lett 2005;5(10):2050–7.</mixed-citation><mixed-citation xml:lang="ru">Chen C., Xing G., Wang J. et al. Multihydroxylated [Gd@C82(OH)22]n nanoparticles: antineoplastic activity of high efficiency and low toxicity. Nano Lett 2005;5(10):2050–7.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">13. Darwish A.D. Fullerenes. Annu Rep Prog Chem A 2010;106:356–75.</mixed-citation><mixed-citation xml:lang="ru">Darwish A.D. Fullerenes. Annu Rep Prog Chem A 2010;106:356–75.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">14. Gao J., Wang H.L., Shreve A., Iyer R. Fullerene derivatives induce premature senescence: A new toxicity paradigm or novel biomedical applications. Toxicol Appl Pharmacol 2010;244:130–43.</mixed-citation><mixed-citation xml:lang="ru">Gao J., Wang H.L., Shreve A., Iyer R. Fullerene derivatives induce premature senescence: A new toxicity paradigm or novel biomedical applications. Toxicol Appl Pharmacol 2010;244:130–43.</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">15. Jung H., Wang C., Jang W. Nano-C60 and hydroxylated C60: Their impacts on the environment. Toxicol Envir Health Sci 2009;1:132–9.</mixed-citation><mixed-citation xml:lang="ru">Jung H., Wang C., Jang W. Nano-C60 and hydroxylated C60: Their impacts on the environment. Toxicol Envir Health Sci 2009;1:132–9.</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">16. Сидоров Л.Н., Юровская М.А., Борщевский А.Я. и др. Фуллерены. М.: Экзамен, 2005.</mixed-citation><mixed-citation xml:lang="ru">Сидоров Л.Н., Юровская М.А., Борщевский А.Я. и др. Фуллерены. М.: Экзамен, 2005.</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">17. Hirsch A., Brettreich M. Fullerenes: chemistry and reactions. Weinheim, Wiley- VCH, 2005.</mixed-citation><mixed-citation xml:lang="ru">Hirsch A., Brettreich M. Fullerenes: chemistry and reactions. Weinheim, Wiley- VCH, 2005.</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">18. Пиотровский Л.Б., Киселев О.И. Фуллерены в биологии. СПб.: Росток, 2006.</mixed-citation><mixed-citation xml:lang="ru">Пиотровский Л.Б., Киселев О.И. Фуллерены в биологии. СПб.: Росток, 2006.</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">19. Трошин П.А., Любовская З.Н. Органическая химия фуллеренов: основные реакции, типы соединений фуллеренов и перспективы их практического приме- нения. Успехи химии 2008;77:324–69.</mixed-citation><mixed-citation xml:lang="ru">Трошин П.А., Любовская З.Н. Органическая химия фуллеренов: основные реакции, типы соединений фуллеренов и перспективы их практического приме- нения. Успехи химии 2008;77:324–69.</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">20. Ema M., Kobayashi N., Naya M., Hanai S. et al. Reproductive and developmental toxicity studies of manufactured nanomaterials. J Reprod Toxicol 2010;30:343–52.</mixed-citation><mixed-citation xml:lang="ru">Ema M., Kobayashi N., Naya M., Hanai S. et al. Reproductive and developmental toxicity studies of manufactured nanomaterials. J Reprod Toxicol 2010;30:343–52.</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">21. Markovic Z., Trajkovic V. Biomedical potential of the reactive oxygen species generation and quenching by fullerenes (C60). Biomaterials 2008;29:3561–73.</mixed-citation><mixed-citation xml:lang="ru">Markovic Z., Trajkovic V. Biomedical potential of the reactive oxygen species generation and quenching by fullerenes (C60). Biomaterials 2008;29:3561–73.</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">22. Grausova L., Vacik J., Vorlicek V. et al. Fullerene C60 films of continuous and micropatterned morphology as substrates for adhesion and growth of bone cells. Diamond Relat Mater 2009;18:578–86.</mixed-citation><mixed-citation xml:lang="ru">Grausova L., Vacik J., Vorlicek V. et al. Fullerene C60 films of continuous and micropatterned morphology as substrates for adhesion and growth of bone cells. Diamond Relat Mater 2009;18:578–86.</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">23. Aschberger K., Johnston H.J., Stone V. et al. Review of fullerene toxicity andexposure – Appraisal of a human health risk assessment, based on open literature. Regul Toxicol Pharmacol 2010;58:455–73.</mixed-citation><mixed-citation xml:lang="ru">Aschberger K., Johnston H.J., Stone V. et al. Review of fullerene toxicity andexposure – Appraisal of a human health risk assessment, based on open literature. Regul Toxicol Pharmacol 2010;58:455–73.</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">24. Da Ros T., Spalluto G., Prato M. Biological applications of fullerene derivatives: a brief overview. Croat Chem Acta 2001;74:743–55.</mixed-citation><mixed-citation xml:lang="ru">Da Ros T., Spalluto G., Prato M. Biological applications of fullerene derivatives: a brief overview. Croat Chem Acta 2001;74:743–55.</mixed-citation></citation-alternatives></ref><ref id="B25"><label>25.</label><citation-alternatives><mixed-citation xml:lang="en">25. Da Ros T. Twenty Years of Promises: Fullerene in Medicinal Chemistry. In.: Medicinal Chemistry and Pharmacological Potential of Fullerenes and Carbon Nanotubes. Series: Carbon Materials: Chemistry and Physics, Vol. 1, 2008. Pp. 1–21.</mixed-citation><mixed-citation xml:lang="ru">Da Ros T. Twenty Years of Promises: Fullerene in Medicinal Chemistry. In.: Medicinal Chemistry and Pharmacological Potential of Fullerenes and Carbon Nanotubes. Series: Carbon Materials: Chemistry and Physics, Vol. 1, 2008. Pp. 1–21.</mixed-citation></citation-alternatives></ref><ref id="B26"><label>26.</label><citation-alternatives><mixed-citation xml:lang="en">26. Bakry R., Vallant R.M., Najam-ul-Haq M. et al. Medicinal applications of fullerenes. Int J Nanomed 2007;4:639–49.</mixed-citation><mixed-citation xml:lang="ru">Bakry R., Vallant R.M., Najam-ul-Haq M. et al. Medicinal applications of fullerenes. Int J Nanomed 2007;4:639–49.</mixed-citation></citation-alternatives></ref><ref id="B27"><label>27.</label><citation-alternatives><mixed-citation xml:lang="en">27. Satoh M., Takayanagi I. Pharmacological Studies on Fullerene (C60), a Novel Carbon Allotrope, and Its Derivatives. J Pharmacol Sci 2006;100:513–8.</mixed-citation><mixed-citation xml:lang="ru">Satoh M., Takayanagi I. Pharmacological Studies on Fullerene (C60), a Novel Carbon Allotrope, and Its Derivatives. J Pharmacol Sci 2006;100:513–8.</mixed-citation></citation-alternatives></ref><ref id="B28"><label>28.</label><citation-alternatives><mixed-citation xml:lang="en">28. Chawla P., Chawla V., Maheshwari R., Saraf A. Fullerenes: from carbon to nanomedicine. Mini Reviews in Med Chem 2010;10:662–77.</mixed-citation><mixed-citation xml:lang="ru">Chawla P., Chawla V., Maheshwari R., Saraf A. Fullerenes: from carbon to nanomedicine. Mini Reviews in Med Chem 2010;10:662–77.</mixed-citation></citation-alternatives></ref><ref id="B29"><label>29.</label><citation-alternatives><mixed-citation xml:lang="en">29. Partha R., Conyers J.L. Biomedical applications of functionalized fullerenebased nanomaterials. Int J Nanomed 2009;4:261–75.</mixed-citation><mixed-citation xml:lang="ru">Partha R., Conyers J.L. Biomedical applications of functionalized fullerenebased nanomaterials. Int J Nanomed 2009;4:261–75.</mixed-citation></citation-alternatives></ref><ref id="B30"><label>30.</label><citation-alternatives><mixed-citation xml:lang="en">30. Yan L., Zhao F., Li S. et al. Low-toxic and safe nanomaterials by surface-chemical design, carbon nanotubes, fullerenes, metallofullerenes, and graphenes. Nanoscale 2011;3:362–82.</mixed-citation><mixed-citation xml:lang="ru">Yan L., Zhao F., Li S. et al. Low-toxic and safe nanomaterials by surface-chemical design, carbon nanotubes, fullerenes, metallofullerenes, and graphenes. Nanoscale 2011;3:362–82.</mixed-citation></citation-alternatives></ref><ref id="B31"><label>31.</label><citation-alternatives><mixed-citation xml:lang="en">31. Parveen S., Misra R., Sahoo S.K. Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine 2012;8(2):147–66.</mixed-citation><mixed-citation xml:lang="ru">Parveen S., Misra R., Sahoo S.K. Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine 2012;8(2):147–66.</mixed-citation></citation-alternatives></ref><ref id="B32"><label>32.</label><citation-alternatives><mixed-citation xml:lang="en">32. Huh A.J., Kwon Y.J. «Nanoantibiotics»: A new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. J Control Release 2011;7:128–45.</mixed-citation><mixed-citation xml:lang="ru">Huh A.J., Kwon Y.J. «Nanoantibiotics»: A new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. J Control Release 2011;7:128–45.</mixed-citation></citation-alternatives></ref><ref id="B33"><label>33.</label><citation-alternatives><mixed-citation xml:lang="en">33. Койфман О.И., Мамардашвили Н.Ж., Антипин И.С. Синтетические рецепторы на основе порфиринов и их конъюгатов с каликс[4]аренами. М.: Наука, 2006.</mixed-citation><mixed-citation xml:lang="ru">Койфман О.И., Мамардашвили Н.Ж., Антипин И.С. Синтетические рецепторы на основе порфиринов и их конъюгатов с каликс[4]аренами. М.: Наука, 2006.</mixed-citation></citation-alternatives></ref><ref id="B34"><label>34.</label><citation-alternatives><mixed-citation xml:lang="en">34. Satake A., Kobuke Y. Dynamic supramolecular porphyrin system. Tetrahedron 2005;61:13–41.</mixed-citation><mixed-citation xml:lang="ru">Satake A., Kobuke Y. Dynamic supramolecular porphyrin system. Tetrahedron 2005;61:13–41.</mixed-citation></citation-alternatives></ref><ref id="B35"><label>35.</label><citation-alternatives><mixed-citation xml:lang="en">35. Tykhomyrov A.A., Nedzvetsky V.S., Klochkov V.K., Andrievsky G.V. Nanostructures of hydrated C60 fullerene (C60HyFn) protect rat brain against alcohol impact and attenuate behavioral impairments of alcoholized animals. Toxicology 2008;246:158–65.</mixed-citation><mixed-citation xml:lang="ru">Tykhomyrov A.A., Nedzvetsky V.S., Klochkov V.K., Andrievsky G.V. Nanostructures of hydrated C60 fullerene (C60HyFn) protect rat brain against alcohol impact and attenuate behavioral impairments of alcoholized animals. Toxicology 2008;246:158–65.</mixed-citation></citation-alternatives></ref><ref id="B36"><label>36.</label><citation-alternatives><mixed-citation xml:lang="en">36. Buseck P.R. Geological fullerenes: review and analysis. Earth Planet Sci Lett 2002;203:781–92.</mixed-citation><mixed-citation xml:lang="ru">Buseck P.R. Geological fullerenes: review and analysis. Earth Planet Sci Lett 2002;203:781–92.</mixed-citation></citation-alternatives></ref><ref id="B37"><label>37.</label><citation-alternatives><mixed-citation xml:lang="en">37. Shinohara N., Gamo M., Nakanishi J. Fullerene C60: inhalation hazard assessment and derivation of a period-limited acceptable exposure level. Toxicol Sci 2011;123:576–89.</mixed-citation><mixed-citation xml:lang="ru">Shinohara N., Gamo M., Nakanishi J. Fullerene C60: inhalation hazard assessment and derivation of a period-limited acceptable exposure level. Toxicol Sci 2011;123:576–89.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
